“Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy”, IHJPAS, vol. 31, no. 3, pp. 63–69, Nov. 2018, doi: 10.30526/31.3.2011.